05/31/2017 - 06/01/2017
China and Life Sciences
Zhuhai International Convention and Exhibit Center Shizimen CBD Nanwan Avenue Zhuhai, China 519030
Thomas T.H. Chou and Janet Xiao
Strong licensing, partnership, and acquisition deals between China and the US are helping to drive growth of pharmaceutical and biotech companies in these countries. While pharmaceutical companies are leveraging such deals to position themselves in the worldwide market, investors are serving as a bridge for companies on both sides of the border to maximize growth potential. In this session, we will discuss how this strategy is being employed and will look closely at onshore and offshore deal structures as a means of driving global success.
©1996-2019 Morrison & Foerster LLP. All rights reserved.